Egr-1 and Sp1 interact functionally with the 5-lipoxygenase promoter and its naturally occurring mutants

被引:92
作者
Silverman, ES
Du, J
De Sanctis, GT
Rådmark, O
Samuelsson, B
Drazen, JM
Collins, T
机构
[1] Brigham & Womens Hosp, Dept Pathol, Div Vasc Res, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, Stockholm, Sweden
关键词
D O I
10.1165/ajrcmb.19.2.3154
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
5-Lipoxygenase (5-LO), an enzyme essential for the formation of leukotrienes, is functionally modulated by a number of mechanisms, including transcriptional controls. The 5-LO promoter has a unique G+C-rich sequence, located between 176 and 147 base pairs upstream of the ATG translation start site, which contains five tandem Sp1 (a zinc-finger transcription factor) consensus binding sites overlapping five tandem early growth response protein 1 (Egr-1), a zinc-finger transcription factor, consensus binding sites. A family of naturally occurring mutations has been identified that consists of additions or deletions of these binding sites. The role of these overlapping Sp1/Egr-1 sites in the regulation of 5-LO transcription and the effects of these mutations on transcriptional regulatory mechanisms are unknown. We now show that Spl and Egr-1 bind specifically to the G+C-rich promoter sequence using in vitro deoxyribonuclease I footprinting. Both Sp1 and Egr-1 activate 5-LO promoter-reporter constructs in a minimally active drosophila SL2 cotransfection system, and the G+C-rich sequence is involved in this process. Moreover, studies comparing mutant promoter function indicate that both Spl and Egr-1 trans-activation are proportional to the number of Sp1/Egr-1 consensus binding sites within the G+C-rich sequence. It is possible that basal and inducible 5-LO gene transcriptions are mediated by an interplay of Sp1, Egr-1, and other transcription factors within the G+C-rich promoter region, and the naturally occurring mutations alter transcription by modifying their trans-activation potential.
引用
收藏
页码:316 / 323
页数:8
相关论文
共 26 条
[1]   AIRWAY RESPONSIVENESS TO LEUKOTRIENE-C4 AND LEUKOTRIENE-D4 AND TO METHACHOLINE IN PATIENTS WITH ASTHMA AND NORMAL CONTROLS [J].
ADELROTH, E ;
MORRIS, MM ;
HARGREAVE, FE ;
OBYRNE, PM .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (08) :480-484
[2]  
Ausubel FM., 1993, Current Protocols in Molecular Biology
[3]   THE EFFECT OF AN ORAL LEUKOTRIENE ANTAGONIST L-649,923 ON HISTAMINE AND LEUKOTRIENE-D4-INDUCED BRONCHOCONSTRICTION IN NORMAL MAN [J].
BARNES, N ;
PIPER, PJ ;
COSTELLO, J .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 79 (05) :816-821
[4]   REGULATION OF 5-LIPOXYGENASE AND 5-LIPOXYGENASE-ACTIVATING PROTEIN EXPRESSION IN HL-60 CELLS [J].
BENNETT, CF ;
CHIANG, MY ;
MONIA, BP ;
CROOKE, ST .
BIOCHEMICAL JOURNAL, 1993, 289 :33-39
[5]  
COUREY AJ, 1992, TRANSCRIPTIONAL REGU, V28, P743
[6]   CLONING OF THE CDNA FOR HUMAN 5-LIPOXYGENASE [J].
DIXON, RAF ;
JONES, RE ;
DIEHL, RE ;
BENNETT, CD ;
KARGMAN, S ;
ROUZER, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (02) :416-420
[7]   CHARACTERIZATION OF THE HUMAN 5-LIPOXYGENASE GENE [J].
FUNK, CD ;
HOSHIKO, S ;
MATSUMOTO, T ;
RADMARK, O ;
SAMUELSSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) :2587-2591
[8]   EARLY GROWTH-RESPONSE PROTEIN 1(EGR-1) - PROTOTYPE OF A ZINC-FINGER FAMILY OF TRANSCRIPTION FACTORS [J].
GASHLER, A ;
SUKHATME, VP .
PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 50, 1995, 50 :191-224
[9]   CHARACTERIZATION OF THE HUMAN 5-LIPOXYGENASE GENE PROMOTER [J].
HOSHIKO, S ;
RADMARK, O ;
SAMUELSSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (23) :9073-9077
[10]   Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription [J].
In, KH ;
Asano, K ;
Beier, D ;
Grobholz, J ;
Finn, PW ;
Silverman, EK ;
Silverman, ES ;
Collins, T ;
Fischer, AR ;
Keith, TP ;
Serino, K ;
Kim, SW ;
DeSanctis, GT ;
Yandava, C ;
Pillari, A ;
Rubin, P ;
Kemp, J ;
Israel, E ;
Busse, W ;
Ledford, D ;
Murray, JJ ;
Segal, A ;
Tinkleman, D ;
Drazen, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (05) :1130-1137